SHAREHOLDER ALERT: WeissLaw LLP Reminds XEC, MMAC, SBBP, and HRVSF Shareholders About Its Ongoing Investigations

0
20

NEW YORK, June 01, 2021 (GLOBE NEWSWIRE) —

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Cimarex Energy Co. (NYSE: XEC)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Cimarex Energy Co. (NYSE: XEC) in connection with the proposed merger of the company with Cabot Oil & Gas Corporation (“Cabot”). Under the terms of the merger agreement, XEC shareholders will receive 4.0146 shares of Cabot common stock for each share of XEC common stock that they own, representing implied per-share merger consideration of approximately $65.84 based upon Cabot’s May 28, 2021 closing price of $16.40. If you own XEC shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslawllp.com/xec/

MMA Capital Holdings, Inc. (NASDAQ: MMAC)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of MMA Capital Holdings, Inc. (NASDAQ: MMAC) in connection with the proposed acquisition of the company by an affiliate of Fundamental Advisors LP. Under the terms of the merger agreement, the company’s shareholders will receive $27.77 per share in cash. If you own MMAC shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslawllp.com/mmac/

Strongbridge Biopharma plc (NASDAQ: SBBP)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Strongbridge Biopharma plc (NASDAQ: SBBP) in connection with the company’s proposed merger with Xeris Pharmaceuticals, Inc. (“Xeris”). Under the terms of the merger agreement, SBBP shareholders will receive 0.7840 shares of Xeris common stock for each share of SBBP common stock that they own, representing implied per-share merger consideration of approximately $2.45 based upon Xeris’ May 28, 2021 closing price of $3.12. If you own SBBP shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslawllp.com/sbbp/

Harvest Health & Recreation Inc. (OTC: HRVSF)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Harvest Health & Recreation Inc. (OTC: HRVSF) in connection with the proposed acquisition of the company by Trulieve Cannabis Corp. (“Trulieve”).   Pursuant to the merger agreement, HRVSF shareholders will receive 0.1170 shares of Trulieve common stock for each HRVSF share that they own, representing implied per-share merger consideration of approximately $4.44 based upon Trulieve’s May 28, 2021 closing price of $37.96. If you own HRVSF shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslawllp.com/hrvsf/

LEAVE A REPLY

Please enter your comment!
Please enter your name here